- Home
- PARR vs CRMD Comparison
PARR vs CRMD Comparison
Compare PARR & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PARR
- CRMD
- Stock Information
- Founded
- PARR 1984
- CRMD 2006
- Country
- PARR United States
- CRMD United States
- Employees
- PARR N/A
- CRMD N/A
- Industry
- PARR Integrated oil Companies
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- PARR Energy
- CRMD Health Care
- Exchange
- PARR Nasdaq
- CRMD Nasdaq
- Market Cap
- PARR 1.2B
- CRMD 973.3M
- IPO Year
- PARR N/A
- CRMD 2010
- Fundamental
- Price
- PARR $27.87
- CRMD $13.61
- Analyst Decision
- PARR Buy
- CRMD Strong Buy
- Analyst Count
- PARR 7
- CRMD 7
- Target Price
- PARR $22.96
- CRMD $15.29
- AVG Volume (30 Days)
- PARR 1.4M
- CRMD 1.4M
- Earning Date
- PARR 08-05-2025
- CRMD 08-13-2025
- Dividend Yield
- PARR N/A
- CRMD N/A
- EPS Growth
- PARR N/A
- CRMD N/A
- EPS
- PARR N/A
- CRMD 0.28
- Revenue
- PARR $7,738,658,000.00
- CRMD $82,553,827.00
- Revenue This Year
- PARR N/A
- CRMD $238.38
- Revenue Next Year
- PARR N/A
- CRMD $53.52
- P/E Ratio
- PARR N/A
- CRMD $48.60
- Revenue Growth
- PARR N/A
- CRMD N/A
- 52 Week Low
- PARR $11.86
- CRMD $3.61
- 52 Week High
- PARR $28.30
- CRMD $15.38
- Technical
- Relative Strength Index (RSI)
- PARR 83.14
- CRMD 57.69
- Support Level
- PARR $21.01
- CRMD $13.83
- Resistance Level
- PARR $22.00
- CRMD $14.99
- Average True Range (ATR)
- PARR 1.13
- CRMD 0.69
- MACD
- PARR 0.41
- CRMD -0.14
- Stochastic Oscillator
- PARR 94.31
- CRMD 45.71
About PARR Par Pacific Holdings Inc.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.